Medical cannabis firms invest in Europe, Americans look to expand

Medical cannabis in Germany continues to excite Canadian companies interested in the sector. Anticipation over further loosening of regulations continues to spur investment in the EU.

Meanwhile, the US continues to be an important CBD market, with two American companies looking to create wider distribution networks.

PotNetwork Holdings will roll out a series of carts and kiosks in south Florida for its Diamond CBD brand, gives Diamond the chance to educate people on CBD. The Integrated Cannabis Company has partnered with Empower Clinics, an operator of medical cannabis and wellness clinics in the US, to distribute its X-Sprays brand.

Read full article
I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization